Daily Archives: November 15, 2022

Guideline | Management of hyperosmolar hyperglycemic state in adults.

15 Nov, 2022 | 13:03h | UTC

Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group – Diabetic Medicine

Related: Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients – The BMJ

 

---

AHA Scientific Statement | An overview of telehealth in the management of cardiovascular disease.

15 Nov, 2022 | 13:01h | UTC

An Overview of Telehealth in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation

News Release: Telehealth is a valuable option in cardiovascular care, though challenges remain – American Heart Association

 

---

Phase 2 RCT | Non-hormonal drug reduces vasomotor symptoms in women taking oral adjuvant endocrine therapy after breast cancer.

15 Nov, 2022 | 12:58h | UTC

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial – The Lancet

Commentary: Non-hormonal therapy reduces hot flashes and night sweats in women who have been diagnosed with breast cancer – Monash University 

 

---

RCT | Bivalirudin is superior to heparin in patients with ST-segment elevation myocardial infarction undergoing primary PCI.

15 Nov, 2022 | 13:00h | UTC

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial – The Lancet

Commentaries:

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI – TCTMD

Bivalirudin found to be safer and more effective than heparin for treating heart attack patients undergoing percutaneous coronary intervention – Mount Sinai School of Medicine

BivaliRudin with prolonged full-dose Infusion during primary PCI versus Heparin Trial – BRIGHT-4 – American College of Cardiology

 

---

RCT | Evaluation of two short, standardized regimens for the treatment of rifampicin-resistant tuberculosis.

15 Nov, 2022 | 12:57h | UTC

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial – The Lancet

Commentary: 

Shorter treatment effective for drug-resistant tuberculosis – University College London

Shorter Treatment Regimen for Drug-Resistant TB is More Effective – Health Policy Watch

 

---

2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in rheumatic diseases.

15 Nov, 2022 | 12:55h | UTC

2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases – Annals of the Rheumatic Diseases

 

Commentary on Twitter

https://twitter.com/ARD_BMJ/status/1590254371257946112

 

---

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

15 Nov, 2022 | 12:52h | UTC

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

 

Commentary from the author on Twitter

https://twitter.com/ArndtVogel/status/1590634413377081344

 

---

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological DMARDs.

15 Nov, 2022 | 12:53h | UTC

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update – Annals of the Rheumatic Diseases

Commentary: Updated EULAR recommendations on the use of DMARDs for people with RA – News Medical

 

---

RCT | Genicular nerve block offers short-term pain relief in patients with knee osteoarthritis.

15 Nov, 2022 | 12:50h | UTC

Genicular Nerve Block for Pain Management in Patients With Knee Osteoarthritis: A Randomized Placebo-Controlled Trial – Arthritis & Rheumatology

Commentary: Genicular nerve block may provide short-term pain relief for knee osteoarthritis – medwire News

 

---

RCT | Comparison of acupuncture vs. sham acupuncture in the treatment of aromatase inhibitor–related joint pain.

15 Nov, 2022 | 12:47h | UTC

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain: A Randomized Clinical Trial – JAMA Network Open

Commentary: Aromatase inhibitors and acupuncture in breast cancer: Spinning a negative study, four years later – Science-based Medicine

 

Commentary on Twitter

https://twitter.com/JAMANetworkOpen/status/1591113526222913538

 

---